A retrospective study comparing persistence of newer DHHS guideline- recommended single- and multiple- tablet regimens (STRs and MTRs) for treatment- naïve patients
Latest Information Update: 29 Dec 2021
At a glance
- Drugs Bictegravir/emtricitabine/tenofovir alafenamide (Primary) ; Dolutegravir (Primary) ; Emtricitabine/tenofovir alafenamide (Primary) ; Emtricitabine/tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Therapeutic Use
Most Recent Events
- 29 Dec 2021 New trial record
- 30 Oct 2021 Results presented at the 18th European AIDS Conference